English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18034/20233 (89%)
造訪人次 : 23347541      線上人數 : 444
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/24228


    標題: 6-Alkylamino-2-(3-hydroxyphenyl)quinoIin-4-one Derivatives Induced Mitotic Arrest in Human Hep3B Cells
    作者: Mei-Hua Hsu (徐美華)
    Li-Chen Chou (周立琛)
    Ming-Hua Chen (陳明華)
    Chi-Hung Huang (黃濟鴻)
    Hui-Yi Lin (林慧怡)
    Shi-Hon Zhuang (莊仕弘)
    Chien-Ting Chen (陳建廷)
    Li-Jiau Huang (黃麗嬌)
    Sheng-Chu Kuo ()
    日期: 2011
    上傳時間: 2011-06-23 14:57:19 (UTC+8)
    摘要: In order to develop potential backup compounds for our previous identified new anticancer drug candidate,CHM-l-P-Na, a series of 6-alkylamino-2-(3-hydroxyphenyl)quinolin-4-one derivatives were designed and synthesized. The newly synthesized derivatives were evaluated for cytotoxicity and structure-activity relationships were established. Among those tested compounds, 6-pyrrolidino-2-(3-hydroxyphenyl)quinolin-4-one (A) was the most promising agent which was submitted to NCI for evaluation against 60 human cancer cell lines. Furthermore, the monophosphate of compound A (A-P) was synthesized and evaluated for antitumor activity in Hep3B Xenograft nude mice model. The results indicated that compound A-P has excellent antitumor activity when administrated either iv or po. With excellent antitumor activity profiles, compound A-P is considered potential backup compound for CHM-l-P-Na, which is currently under preclinical study.
    關聯: 2011年台俄有機、藥物與生物化學交流暨藥物化學研討會,起迄日:2011/04/06~2011/04/05,地點:溪頭台大實驗林
    顯示於類別:[藥理學院] 2011年台俄有機、藥物與生物化學交流暨藥物化學研討會

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    pp-12.pdf70KbAdobe PDF608檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋